1. The signal transduction pathway responsible for cAMP-dependent Ca2+-indu
ced Ca2+ release (CICR) from endoplasmic reticulum. Ca2+ stores was assesse
d in the insulin-secreting cell line INS-1.
2. CICR was triggered by the GLP-1 receptor agonist exendin-4, an effect mi
micked by caffeine, Sp-cAMPS or forskolin, CICR required influx of Ca2+ thr
ough L-type voltage-dependent Ca2+ channels, and was blocked by treatment w
ith nimodipine, thapsigargin, or ryanodine, but not by the IP3 receptor ant
agonist xestospongin C.
3. Treatment with the cAMP antagonist 8-Br-Rp-cAMPS blocked CICR in respons
e to exendin-4, whereas the PKA inhibitor H-89 was ineffective when tested
at a concentration demonstrated to inhibit PKA-dependent gene expression.
4. RT-PCR of INS-1 cells demonstrated expression of mRNA coding for the typ
e-II isoform of cAMP-regulated guanine nucleotide exchange factor (cAMP-GEF
-II, Epac2).
5. CICR in response to forskolin was blocked by transient transfection and
expression of a dominant negative mutant isoform of cAMP-GEF-II in which in
activating mutations were introduced into the exchange factor's two cAMP-bi
nding domains.
6. It is concluded that CICR in INS-1 cells results from GLP-1 receptor-med
iated sensitization of the intracellular Ca2+ release mechanism, a signal t
ransduction pathway independent of PKA, but which requires cAMP-GEF-II.